D.E. Shaw & Co’s Zynerba Pharmaceuticals ZYNE Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYNE
D.E. Shaw & Co's ZYNE Position: Q1 2023 in Review
D.E. Shaw & Co sold out of Zynerba Pharmaceuticals (ZYNE) in Q1 2023, closing a stake of 195,064 shares — an estimated $103K sold.
D.E. Shaw & Co first reported a position in ZYNE in Q3 2017 and held it in 10 quarters. The position peaked at $5.96M in Q3 2021. 44 funds tracked by Wall St. Rank hold ZYNE as of Q1 2023.
- D.E. Shaw & Co reported no remaining Zynerba Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
- D.E. Shaw & Co sold 195,064 Zynerba Pharmaceuticals shares in Q1 2023, an estimated $103K.
- D.E. Shaw & Co first reported a position in Zynerba Pharmaceuticals in Q3 2017 and held it in 10 quarters.
- D.E. Shaw & Co's Zynerba Pharmaceuticals position peaked at $5.96M in Q3 2021.
- 44 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals as of Q1 2023.
Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.